# Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks

> **NCT02810483** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 69 (actual)

## Conditions studied

- Prader-Willi Syndrome

## Interventions

- **DRUG:** Topiramate
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT02810483
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2015-11
- **Final completion:** 2016-06
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2018-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02810483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02810483, "Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02810483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*